Drug design for hemagglutinin: Screening and molecular dynamics from traditional Chinese medicine database
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Journal of the Taiwan Institute of Chemical Engineers
- Vol. 42 (4) , 563-571
Abstract
No abstract availableKeywords
Funding Information
- National Science Council (NSC 99-2221-E-039-013)
- Asia University (CMU98-ASIA-09)
- National Center of Excellence for Clinical Trial and Research (DOH99-TD-B-111-004)
- China Medical University (CMU98-TCM, CMU99-S-02)
This publication has 24 references indexed in Scilit:
- Virtual Screening and Drug Design for PDE-5 Receptor from Traditional Chinese Medicine DatabaseJournal of Biomolecular Structure and Dynamics, 2010
- Drug design for Influenza A virus subtype H1N1Journal of the Taiwan Institute of Chemical Engineers, 2010
- Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, ChinaEmerging Infectious Diseases, 2009
- Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)Emerging Infectious Diseases, 2009
- The Influenza Virus EnigmaCell, 2009
- Clustal W and Clustal X version 2.0Bioinformatics, 2007
- Pandemic Influenza: The Inside StoryPLOS Biology, 2006
- The Structure and Receptor Binding Properties of the 1918 Influenza HemagglutininScience, 2004
- Assessment of protein models with three-dimensional profilesNature, 1992
- Stereochemistry of polypeptide chain configurationsJournal of Molecular Biology, 1963